Chimeric Therapeutics Limited
CHMMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,054 | $31,328 | $8,127 | $33,886 |
| - Cash | $5,757 | $3,053 | $2,363 | $18,382 |
| + Debt | $0 | $3,594 | $0 | $0 |
| Enterprise Value | -$3,703 | $31,869 | $5,764 | $15,505 |
| Revenue | $3,969 | $0 | $4,506 | $2,617 |
| % Growth | – | -100% | 72.2% | – |
| Gross Profit | $3,122 | -$4 | $4,506 | $1,667 |
| % Margin | 78.7% | – | 100% | 63.7% |
| EBITDA | -$9,077 | -$11,224 | -$24,016 | -$13,623 |
| % Margin | -228.7% | – | -533% | -520.5% |
| Net Income | -$10,430 | -$12,530 | -$25,500 | -$15,898 |
| % Margin | -262.8% | – | -566% | -607.5% |
| EPS Diluted | -0.008 | -0.018 | -0.059 | -0.044 |
| % Growth | 57.2% | 69.4% | -33.3% | – |
| Operating Cash Flow | -$7,276 | -$7,538 | -$16,316 | -$13,153 |
| Capital Expenditures | $0 | $0 | -$112 | -$538 |
| Free Cash Flow | -$7,276 | -$7,538 | -$16,428 | -$13,691 |